Correlation between unproven therapies and delayed return-to-work for COVID-19-infected healthcare workers.

Archives of environmental & occupational health Pub Date : 2024-01-01 Epub Date: 2024-05-20 DOI:10.1080/19338244.2024.2353264

Mouloud Bouhadfane, Elisabetta Monfardini, Anderson Loundou, Pierre Roy, Françoise Martin, Rafika Boufercha, Florence Bajon, Christine Beque, Antoine Villa, Marie-Pascale Lehucher-Michel

{"title":"Correlation between unproven therapies and delayed return-to-work for COVID-19-infected healthcare workers.","authors":"Mouloud Bouhadfane, Elisabetta Monfardini, Anderson Loundou, Pierre Roy, Françoise Martin, Rafika Boufercha, Florence Bajon, Christine Beque, Antoine Villa, Marie-Pascale Lehucher-Michel","doi":"10.1080/19338244.2024.2353264","DOIUrl":null,"url":null,"abstract":"<p><p>The objective of this study is to investigate factors influencing the time to return to work (RTW) of HealthCare Workers (HCW) infected with COVID-19 during the initial wave of the pandemic in a southern French university hospital. Data collection of 170 HCW (between March 16 to June 1, 2020) included demographic and professional information, clinical profiles, comorbidities, medical management, therapies and RT-PCR results. The mean time to RTW was 15.6 days. Multivariate analyses revealed that the time to RTW was shorter among laboratory and emergency workers, while it was longer for HCW aged 40 to 49 years, at higher risk of severe illness, with a delayed negative SARS-CoV-2 PCR or those treated with azithromycin and/or hydroxychloroquine. This study highlights diverse factors affecting HCW RTW post-COVID-19 infection, underscoring the importance of exercising caution in administering unproven therapies to HCW during the early stages of a novel infectious pandemic.</p>","PeriodicalId":93879,"journal":{"name":"Archives of environmental & occupational health","volume":" ","pages":"45-56"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of environmental & occupational health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/19338244.2024.2353264","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/20 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

The objective of this study is to investigate factors influencing the time to return to work (RTW) of HealthCare Workers (HCW) infected with COVID-19 during the initial wave of the pandemic in a southern French university hospital. Data collection of 170 HCW (between March 16 to June 1, 2020) included demographic and professional information, clinical profiles, comorbidities, medical management, therapies and RT-PCR results. The mean time to RTW was 15.6 days. Multivariate analyses revealed that the time to RTW was shorter among laboratory and emergency workers, while it was longer for HCW aged 40 to 49 years, at higher risk of severe illness, with a delayed negative SARS-CoV-2 PCR or those treated with azithromycin and/or hydroxychloroquine. This study highlights diverse factors affecting HCW RTW post-COVID-19 infection, underscoring the importance of exercising caution in administering unproven therapies to HCW during the early stages of a novel infectious pandemic.

查看原文本刊更多论文

感染 COVID-19 的医护人员未经证实的疗法与延迟重返工作岗位之间的相关性。

本研究旨在调查影响法国南部一所大学医院中感染 COVID-19 的医护人员（HCW）重返工作岗位（RTW）时间的因素。170 名医护人员（2020 年 3 月 16 日至 6 月 1 日期间）的数据收集包括人口统计学和专业信息、临床概况、合并症、医疗管理、疗法和 RT-PCR 结果。复工的平均时间为 15.6 天。多变量分析表明，实验室和急救人员的复工时间较短，而年龄在 40 至 49 岁之间、重症风险较高、SARS-CoV-2 PCR 阴性延迟或接受过阿奇霉素和/或羟氯喹治疗的医护人员的复工时间较长。本研究强调了影响感染 COVID-19 后高危工人 RTW 的各种因素，强调了在新型传染病大流行的早期阶段对高危工人谨慎使用未经证实的疗法的重要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Archives of environmental & occupational health

自引率

0.00%

发文量